EVLO Evelo Biosciences Inc Compare

fool

Evelo Biosciences, Inc. Q2 2022 Earnings Call Transcript

yahoo

Evelo Biosciences Presents Late-Breaking Oral Abstract on Data from Phase 2 Trial of EDP1815 in Psoriasis at 2022 American Academy of Dermatology Annual Meeting - Yahoo Finance

yahoo

Evelo Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Business Highlights - Yahoo Finance

fool

Evelo Biosciences, Inc. Q3 2021 Earnings Call Transcript

yahoo

Evelo Biosciences Announces Issuance of U.S. Patent for Pharmaceutical Compositions of Single Strains of Naturally Occurring Bacteria as Medicines - Yahoo Finance

yahoo

Should I Buy Evelo Biosciences, Inc. ?

yahoo

Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture

yahoo

Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening

marketwatch

Biotech companies are trying to solve stubborn illnesses using ‘drugs from bugs’

fool

Evelo Biosciences, Inc. Q1 2021 Earnings Call Transcript

yahoo

Evelo Biosciences to Present at 20th Annual Needham Virtual Healthcare Conference - Yahoo Finance

fool

Evelo Biosciences, Inc. Q4 2020 Earnings Call Transcript

yahoo

Hedge Funds Are Dumping Evelo Biosciences, Inc.

ih.advfn

Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing

yahoo

Evelo Biosciences, Inc. Upgraded to Strong Buy: What Does It Mean for the Stock?

markets.businessinsider

Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

yahoo

Before You Buy Evelo Biosciences, Inc. , Consider Its Volatility

benzinga

85 Biggest Movers From Yesterday

benzinga

61 Stocks Moving In Monday's Mid-Day Session

benzinga

71 Biggest Movers From Yesterday

yahoo

Hedge Funds Have Never Been This Bullish On Evelo Biosciences, Inc.

yahoo

Flagship Unveils Newest Pioneering Platform: Ring Therapeutics

fool

Evelo Biosciences, Inc. Q2 2019 Earnings Call Transcript